Dimaani, Salde .

HRN: 22-09-79  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/22/2022
10/29/2022
IVTT
300mg
Q8h
Intestinal Amoebiasis
Waiting Final Action 
10/22/2022
CEFUROXIME 750MG (VIAL)
10/22/2022
10/29/2022
IVTT
1000mg
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: